The rationale of this study is to establish a robust method for assessing sun protection product efficacy in preventing erythema and tanning. Employing both artificial ultraviolet-A Irradiation and natural direct sunlight exposure, the investigation seeks to provide a reliable methodology, ensuring reproducibility and enabling a direct comparison between these methods. Meticulously determining optimal UV dosages, the study prioritizes inducing skin responses for evaluation while avoiding adverse effects like blistering. The localized validation of UV exposure techniques, tailored to the Indian population, contributes significantly to the field by addressing diverse skin types and environmental conditions. By incorporating both artificial and natural (direct sunlight) UV exposure methods, the study aspires to enhance the safety and effectiveness of future dermatological investigations, benefiting both the scientific community and the broader population.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
6
Apply directly on the designated site till absorbed.
Apply directly on the designated site till absorbed.
NovoBliss Research Pvt Ltd
Gandhinagar, Gujarat, India
Changes in Melanine index using instrumental assessment
Change in melanin index (MI) before and after the exposure as measured using the Changes in melanin index will be measured by using Mexameter® MX 18.
Time frame: Days 1, 3 and 7.
Change in erythema index using instrumental assessment
Change in the erythema index (EI) before and after the exposure as measured using the Mexameter® MX 18.
Time frame: Days 1, 3 and 7.
Change in skin erythema/dryness/wrinkles and oedema using draize scale
Visual change in skin erythema/dryness/wrinkles and oedema of the skin using the Draize scale. Where 0=No reaction, 4=severe erythema/wrinkle/oedema
Time frame: Days 1, 3 and 7.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.